G-Protein coupled receptors: models, mutagenesis, and drug design.
Bikker
J A
JA
Parke-Davis Neuroscience Research Centre, Forvie Site, Robinson Way, Cambridge, United Kingdom CB2 2QB, and Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105, USA.
Trumpp-Kallmeyer
S
S
Humblet
C
C
D000818:Animals; D001436:Bacteriorhodopsins / Q000737:chemistry / Q000378:metabolism; D015195:Drug Design; D019204:GTP-Binding Proteins / Q000378:metabolism*; D006801:Humans; D008024:Ligands; D008958:Models, Molecular; D009154:Mutation; D011487:Protein Conformation; D017982:Receptors, Biogenic Amine / Q000737:chemistry / Q000378:metabolism; D011956:Receptors, Cell Surface / Q000737:chemistry* / Q000235:genetics* / Q000378:metabolism / Q000502:physiology; D018000:Receptors, Peptide / Q000737:chemistry / Q000378:metabolism; D012243:Rhodopsin / Q000737:chemistry / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology
D008024:Ligands; D017982:Receptors, Biogenic Amine; D011956:Receptors, Cell Surface; D018000:Receptors, Peptide; D001436:Bacteriorhodopsins; D012243:Rhodopsin; D019204:GTP-Binding Proteins